Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Science

• Publication date

  2010-04-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1126/science.1183424PMID 20378816
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia

  2009cited by this paper
• RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation

  2008cited by this paper
• Monomethylarsenite competes with Zn2+ for binding sites in the glucocorticoid receptor.

  2008cited by this paper
• PML targeting eradicates quiescent leukaemia-initiating cells

  2008cited by this paper
• Acute promyelocytic leukemia: from highly fatal to highly curable.

  2008cited by this paper
• Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation

  2008cited by this paper
• Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway

  2008cited by this paper
• Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide

  2007cited by this paper
• Identification of arsenic-binding proteins in human breast cancer cells.

  2007cited by this paper
• Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy

  2007cited by this paper
• Thermodynamics of the As(III)-thiol interaction: arsenite and monomethylarsenite complexes with glutathione, dihydrolipoic acid, and other thiol ligands.

  2005cited by this paper
• Mammalian cell–based optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and affinity

  2005cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia

  2003cited by this paper
• Interaction of trivalent arsenicals with metallothionein.

  2003cited by this paper
• The MXAN procedure: a new method for analysing the XANES spectra of metalloproteins to obtain structural quantitative information.

  2003cited by this paper
• How acute promyelocytic leukaemia revived arsenic

  2002cited by this paper
• PML protein isoforms and the RBCC/TRIM motif

  2001cited by this paper
• Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation

  2001cited by this paper
• SUMO-1 modification of the acute promyelocytic leukaemia protein PML: implications for nuclear localisation.

  1999cited by this paper
• Retinoic Acid Induces Proteasome-Dependent Degradation of Retinoic Acid Receptor α (RARα) and Oncogenic RARα Fusion Proteins

  1999cited by this paper
• Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia

  1999cited by this paper
• Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.

  1999cited by this paper
• Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

  1999cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells.

  1997cited by this paper
• Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients.

  1997cited by this paper
• Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.

  1997cited by this paper
• In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML.

  1996cited by this paper
• Spatial Proximity of Cys113, Cys172, and Cys422 in the Metalloactivation Domain of the ArsA ATPase*

  1996cited by this paper
• The solution structure of the RING finger domain from the acute promyelocytic leukaemia proto‐oncoprotein PML.

  1995cited by this paper
• The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus

  1990cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper
• Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

  1988cited by this paper

• Immune effect of Traditional Chinese Medicine combined with transcatheter arterial chemoembolization in treatment of liver cancer: a meta-analysis

  2026cites this paper
• Dual Protease-Mediated Proteolysis Coupled with Ultrafiltration for System-Level Profiling of Drug Targets and Conformational Dynamics.

  2026cites this paper
• Structural Optimization of Dithiaarsanes-Enhanced Cytotoxicity to Leukemia Cells With Improved Thioredoxin Reductase Inhibition.

  2026cites this paper
• UBE2O-mediated monoubiquitination licenses NLRP6 inflammasome activation in the intestine.

  2026cites this paper
• Pharmacological targeting of oncogenic condensates in cancer: mechanistic insights and therapeutic opportunities.

  2026cites this paper
• A versatile platform for sequential glyco-, phospho-, and proteomics with multi-PTMs integration

  2026cites this paper
• Small-Molecule-Induced Protein Polymerization: Mechanisms and Therapeutic Implications

  2025cites this paper
• Nanocatalytic medicine: An advanced catalysis-based imaging and therapy methodology

  2025cites this paper
• Arsenic trioxide could promote SARS-CoV-2 NSP12 protein degradation

  2025cites this paper
• Curcumin combined with arsenic trioxide enhances autophagy and immune surveillance to inhibit immune escape in acute myeloid leukemia.

  2025cites this paper
• Arsenic compounds in cancer therapy: mechanistic insights and antitumor activity.

  2025cites this paper
• Chemoproteomic Approach for Identifying Nuclear Arsenite-Binding Proteins.

  2025cites this paper
• Direct binding of arsenicals to nuclear transport factors disrupts nucleocytoplasmic transport

  2025cites this paper
• Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019–2024)

  2025cites this paper
• Unlocking a near 1 eV direct band gap, lattice-matched InN-As heterostructure with moist resistance for enhanced optoelectronic applications.

  2025cites this paper
• 急性早幼粒细胞白血病的治愈之路与中国贡献

  2025cites this paper
• PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias

  2025cites this paper
• Simultaneous Tracing of Protein Vicinal Dithiols in Live Cells Using an “Off-on” Fluorescent Probe

  2025cites this paper
• Arsenic binds to nuclear transport factors and disrupts nucleocytoplasmic transport

  2025cites this paper
• Atypical acute promyelocytic leukemia with tripartite fusion gene PML::RARG::LINE-L2a is resistant to ATRA but sensitive to arsenic-based therapy

  2025cites this paper
• Targeting USP2 induces degradation of PML-RARα with or without drug-resistant mutations in acute promyelocytic leukemia

  2025cites this paper
• Discovery of an LSD1 PROTAC degrader

  2025cites this paper
• Attenuation of arsenic trioxide‐induced endothelial injury: unveiling the protective role of ginkgolic acid through inhibition of TRPM4 SUMOylation: Evidence from Raman cellular imaging

  2025cites this paper
• Decoding the Implications of Zinc in the Development and Therapy of Leukemia

  2025cites this paper
• Arkadia and Ark2C promote substrate ubiquitylation with multiple E2 enzymes.

  2025cites this paper
• Dynamic Shielding of Arsenic‐loaded Transferrin with Calcium Manganese Carbonate Potentiates Antitumor Effects via Self‐enhanced Synergistic Therapy

  2025cites this paper
• Cloning Expression of Arsenic Binding Protein with GFP Tag in Bl21de3 Strain and its Chracterization

  2025cites this paper
• Enlarged PML-nuclear bodies trigger conflicting cell cycle signal-mediated cytotoxicity in leukemia cells

  2025cites this paper
• XAFS platform at NFPS BL17B at SSRF: extending structural characterization from long-range to short-range orders

  2025cites this paper
• Mutation in the Unrearranged PML Allele Confers Resistance to Arsenic Trioxide in Acute Promyelocytic Leukemia

  2025cites this paper
• Regulatory Role of Zinc in Acute Promyelocytic Leukemia: Cellular and Molecular Aspects with Therapeutic Implications

  2025cites this paper
• Elucidating the risk factors and oncogene drivers of acute myeloid leukemia

  2025cites this paper
• A Tunable Hydrogel Platform Based on Platinum-Containing Polymeric Arsenicals

  2025cites this paper
• Discovery of Drugs Targeting Mutant p53 and Progress in Nano-Enabled Therapeutic Strategy for p53-Mutated Cancers

  2025cites this paper
• A case report of TBL1XR1-RARB positive pediatric acute promyelocytic leukemia and literature review

  2025cites this paper
• A novel red-emitting fluorescent probe reveals the depletion of vicinal dithiol-containing proteins in acute alcoholic liver injury (AALI) mice model

  2025cites this paper
• Conditional Binding of Arsenic Trioxide (ATO) to Cysteine-Rich Zinc Finger Motifs within RBCC Domain of PML Protein.

  2025cites this paper
• Perturbing LSD1 and WNT rewires transcription to synergistically induce AML differentiation

  2025cites this paper
• Design and Synthesis of Thiourea-Conjugating Organic Arsenic D-Glucose with Anticancer Activities

  2024cites this paper
• Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma

  2024cites this paper
• Nuclear Phosphoproteome Reveals Prolyl Isomerase PIN1 as a Modulator of Oncogene-Induced Senescence

  2024cites this paper
• PML Nuclear bodies: the cancer connection and beyond

  2024cites this paper
• Role of the transient receptor potential melastatin 4 in inhibition effect of arsenic trioxide on the tumor biological features of colorectal cancer cell

  2024cites this paper
• Multiple roles of arsenic compounds in phase separation and membraneless organelles formation determine their therapeutic efficacy in tumors

  2024cites this paper
• Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model

  2024cites this paper
• Can arsenic do anything good? Arsenic nanodrugs in the fight against cancer - last decade review.

  2024cites this paper
• Data Mining of Arsenic-Based Small Molecules Geometrics Present in Cambridge Structural Database.

  2024cites this paper
• Targeted protein degradation: from mechanisms to clinic

  2024influential citation
• Critical learning from industrial catalysis for nanocatalytic medicine

  2024influential citation
• Induced protein degradation for therapeutics: past, present, and future

  2024cites this paper
• Reinvent Aliphatic Arsenicals as Reversible Covalent Warheads toward Targeted Kinase Inhibition and Non-acute Promyelocytic Leukemia Cancer Treatment.

  2024cites this paper
• Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides

  2024cites this paper
• Arsenic trioxide impacts hepatitis B virus core nuclear localization and efficiently interferes with HBV infection

  2024cites this paper
• On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer.

  2024cites this paper
• Unravelling the molecular interplay: SUMOylation, PML nuclear bodies and vascular cell activity in health and disease.

  2024cites this paper
• Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia

  2024cites this paper
• Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discovery

  2024cites this paper
• Histidine tag modified magnetic beads for analysis of arsenic binding proteins.

  2024cites this paper
• Nanovaccine of tumor-derived antigenic microparticles for enhancing effect of arsenic trioxide in cancer immunotherapy

  2024cites this paper
• Unraveling the Guardian: p53’s Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies

  2024cites this paper
• Research progress on gene mutations and drug resistance in leukemia.

  2024cites this paper
• Arsenic trioxide and p97 inhibitor synergize against acute myeloid leukemia by targeting nascent polypeptides and activating the ZAKα–JNK pathway

  2024cites this paper
• Working title: Molecular involvement of p53‐MDM2 interactome in gastrointestinal cancers

  2024cites this paper
• The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus

  2024cites this paper
• STAT5B::RARα-positive acute promyelocytic leukemia: Role of next generation sequencing in detection of a rare malignancy

  2024cites this paper
• Recent advances in Nicotine Electrochemical biosensors: a review

  2024cites this paper
• AsIII Selectively Induces a Disorder-to-Order Transition in the Metalloid Binding Region of the AfArsR Protein

  2024cites this paper
• Disruption of cyclin D1 degradation leads to the development of mantle cell lymphoma

  2024cites this paper
• Structural Basis of PML-RARA Oncoprotein Targeting by Arsenic Unravels a Cysteine Rheostat Controlling PML Body Assembly and Function

  2023cites this paper
• Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy

  2023cites this paper
• Arsenic trioxide-induced apoptosis contributes to suppression of viral reservoir in SIV-infected rhesus macaques

  2023cites this paper
• VOZ1 and VOZ2 transcription factors regulate arsenic tolerance and distribution in rice and Arabidopsis

  2023cites this paper
• Hedgehog signaling in tissue homeostasis, cancers and targeted therapies

  2023cites this paper
• UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability

  2023cites this paper
• Chemoselective Fluorogenic Bioconjugation of Vicinal Dithiol-Containing Proteins for Live Cellular Imaging via Small Molecular Conjugate Acceptors.

  2023cites this paper
• Defect activation of atomically thin electrocatalysts for the oxygen evolution reaction

  2023cites this paper
• Recent progress in analytical strategies of arsenic-binding proteomes in living systems

  2023cites this paper
• A Novel Fusion Partner, SP100, Drives Nuclear Dot Localization of ALK in Epithelioid Fibrous Histiocytoma

  2023cites this paper
• CD71-mediated liposomal arsenic-nickel complex combined with all-trans retinoic acid for the efficacy of acute promyelocytic leukemia

  2023cites this paper
• Exploring the Potential of Metal‐Based Candidate Drugs as Modulators of the Cytoskeleton

  2023cites this paper
• Inhibition of splicing factors SF3A3 and SRSF5 contributes to As3+/Se4+ combination-mediated proliferation suppression and apoptosis induction in acute promyelocytic leukemia cells.

  2023cites this paper
• Arsenic Inhibits Proliferation and Induces Autophagy of Tumor Cells in Pleural Effusion of Patients with Non-Small Cell Lung Cancer Expressing EGFR with or without Mutations via PI3K/AKT/mTOR Pathway

  2023cites this paper
• The Promise of Retinoids in the Treatment of Cancer: Neither Burnt Out Nor Fading Away

  2023cites this paper
• Emerging 2D pnictogens: a novel multifunctional photonic nanoplatform for cutting-edge precision treatment.

  2023cites this paper
• A Superphane-based carcerand for arsenic detoxification via imprisoning arsenate

  2023cites this paper
• A "dual-key-and-lock" ratiometric fluorescent probe with biocompatibility and selectivity for imaging vicinal dithiol proteins.

  2023cites this paper
• Targeting p53 pathways: mechanisms, structures and advances in therapy

  2023cites this paper
• In vivo precision imaging of vicinal-dithiol-containing proteins by a FRET molecular probe sensitive to protein environment

  2023cites this paper
• The relevance of arsenic speciation analysis in health & medicine.

  2023cites this paper
• Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.

  2023cites this paper
• Targeting emerging cancer hallmarks by transition metal complexes: Cancer stem cells and tumor microbiome. Part I

  2023cites this paper
• Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials

  2023cites this paper
• Pyrrolidine Dithiocarbamate Enhances the Cytotoxic Effect of Arsenic Trioxide on Acute Promyelocytic Leukemia Cells.

  2023cites this paper
• Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα

  2023cites this paper
• Intrauterine arsenic exposure induces glucose metabolism disorders in adult offspring by targeting TET2-mediated DNA hydroxymethylation reprogramming of HNF4α in developing livers, an effect alleviated by ascorbic acid.

  2023cites this paper
• AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity.

  2023cites this paper
• Elucidating arsenic-bound proteins in the protein data bank: data mining and amino acid cross-validation through Raman spectroscopy

  2023cites this paper
• Deregulated transcription factors in the emerging cancer hallmarks.

  2023cites this paper
• Mechanistic update of Trisenox in blood cancer

  2023cites this paper
• Mechanisms of genotoxicity and proteotoxicity induced by the metalloids arsenic and antimony

  2023cites this paper